Basics Pyxis Oncology, Inc. IPO Date: October 8, 2021 Sector: Healthcare Industry: Biotech Market Cap: $76.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 4.01% Avg Daily Range (30 D): $0.05 | 4.16% Avg Daily Range (90 D): $0.04 | 3.79% Institutional Daily Volume Avg Daily Volume: .55M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .46M Trade Size Avg Trade Size (Sh.): 174 Avg Trade Size (Sh.) (30 D): 181 Avg Trade Size (Sh.) (90 D): 175 Institutional Trades Total Inst.Trades: 48 Avg Inst. Trade: $2.12M Avg Inst. Trade (30 D): $.93M Avg Inst. Trade (90 D): $.93M Avg Inst. Trade Volume: .53M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.71M Avg Closing Trade (30 D): $.93M Avg Closing Trade (90 D): $.93M Avg Closing Volume: 1.15M         News Jun 28, 2024 @ 8:30 PM Pyxis Oncology Reports Inducement Grants Under Nas... Source: Pyxis Oncology Jun 10, 2024 @ 11:30 AM Pyxis Oncology Expands Board of Directors with App... Source: Pyxis Oncology May 30, 2024 @ 11:30 AM Pyxis Oncology to Participate in a Fireside Chat a... Source: Pyxis Oncology May 14, 2024 @ 12:40 PM Pyxis Oncology, Inc. (PYXS) Reports Q1 Loss, Tops ... Source: Zacks Equity Research Apr 12, 2024 @ 1:55 PM Does Pyxis Oncology (PYXS) Have the Potential to R... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.58 $-.35 $-.59 Diluted EPS $-1.58 $-.35 $-.59 Revenue $ $ $ M Gross Profit $ $ $ M Net Income / Loss $ -95.23M $ -21.16M $ -35.57M Operating Income / Loss $ -106.77M $ -22.91M $ -40.07M Cost of Revenue $ $ $ M Net Cash Flow $ -8.49M $ M $ 7.42M PE Ratio